A small clinical trial, the first human trial of its kind, has revealed the importance of a hormone called erythropoietin for effective umbilical cord blood transplants in leukemia and lymphoma patients. Lowering EPO levels in people aids in a process known as homing, where newly transplanted blood stem cells migrate properly to the bone marrow of the patient and begin to restore the body’s ability to make healthy blood and immune cells. The findings have been described inn accompanying editorial as “a breath of fresh air” for overcoming barriers to make this a viable option for many patients. Umbilical Cord
The post Erythropoietin Important For Effective Umbilical Cord Blood Transplants appeared first on ReliaWire.